AAPL334.51+2.24 (+0.67%) ▲|ABBV261.43+4.31 (+1.68%) ▲|ABT102.95+1.00 (+0.98%) ▲|ACN194.28+10.38 (+5.64%) ▲|ADBE264.86+12.63 (+5.01%) ▲|AMAT426.96-29.53 (-6.47%) ▼|AMD494.09-22.05 (-4.27%) ▼|AMGN380.37+3.02 (+0.80%) ▲|AMT177.20-0.65 (-0.37%) ▼|AMZN255.59-1.19 (-0.46%) ▼|AVGO346.64-15.36 (-4.24%) ▼|AXP326.91+2.22 (+0.68%) ▲|BA210.37-0.09 (-0.04%) ▼|BAC60.11-2.59 (-4.12%) ▼|BKNG175.20+1.28 (+0.74%) ▲|BLK1,066.89-12.76 (-1.18%) ▼|BMY64.12+0.48 (+0.75%) ▲|BNY158.30-4.36 (-2.68%) ▼|BRK-B513.81+3.44 (+0.67%) ▲|C133.83-4.99 (-3.59%) ▼|CAT786.08-32.50 (-3.97%) ▼|CL88.34+1.54 (+1.77%) ▲|CMCSA24.98-0.22 (-0.87%) ▼|COF207.37-0.94 (-0.45%) ▼|COP137.69+0.34 (+0.25%) ▲|COST917.05+12.28 (+1.36%) ▲|CRM258.90+11.18 (+4.51%) ▲|CSCO111.49-0.65 (-0.58%) ▼|CVS95.67+1.01 (+1.07%) ▲|CVX213.68-0.39 (-0.18%) ▼|DE681.39+5.65 (+0.84%) ▲|DHR203.41+3.27 (+1.63%) ▲|DIS109.18+2.63 (+2.47%) ▲|DUK118.88-0.54 (-0.45%) ▼|EMR148.37-3.82 (-2.51%) ▼|FDX311.61+0.84 (+0.27%) ▲|GD356.78+0.88 (+0.25%) ▲|GE317.29-6.38 (-1.97%) ▼|GEV873.25-84.02 (-8.78%) ▼|GILD145.74+2.02 (+1.41%) ▲|GM86.41+0.79 (+0.92%) ▲|GOOG345.45+10.00 (+2.98%) ▲|GOOGL348.92+10.42 (+3.08%) ▲|GS990.42-38.76 (-3.77%) ▼|HD310.54+1.80 (+0.58%) ▲|HON199.12-3.25 (-1.60%) ▼|IBM250.89+7.60 (+3.12%) ▲|INTC98.29-4.66 (-4.52%) ▼|INTU338.38+16.81 (+5.23%) ▲|ISRG376.21+7.06 (+1.91%) ▲|JNJ267.88+2.30 (+0.87%) ▲|JPM349.21-7.02 (-1.97%) ▼|KO89.14+0.85 (+0.96%) ▲|LIN464.53-1.70 (-0.36%) ▼|LLY1,145.82+30.12 (+2.70%) ▲|LMT527.84+3.65 (+0.70%) ▲|LOW198.37+1.55 (+0.79%) ▲|LRCX275.82-22.41 (-7.51%) ▼|MA575.04+5.85 (+1.03%) ▲|MCD257.19+4.66 (+1.85%) ▲|MDLZ62.38-0.06 (-0.10%) ▼|MDT93.31+2.35 (+2.58%) ▲|META664.45+16.42 (+2.53%) ▲|MMM162.01-2.96 (-1.79%) ▼|MO70.55+1.57 (+2.27%) ▲|MRK145.46+1.53 (+1.06%) ▲|MS207.18-7.21 (-3.36%) ▼|MSFT509.20+13.57 (+2.74%) ▲|MU926.10-49.17 (-5.04%) ▼|NEE82.21-0.10 (-0.12%) ▼|NFLX80.75+3.35 (+4.32%) ▲|NKE37.15+0.35 (+0.94%) ▲|NOW143.13+10.60 (+7.99%) ▲|NVDA212.42-5.88 (-2.69%) ▼|ORCL143.85-6.44 (-4.28%) ▼|PEP136.61+0.29 (+0.21%) ▲|PFE27.78+0.06 (+0.20%) ▲|PG146.24+0.97 (+0.67%) ▲|PLTR173.30+6.07 (+3.63%) ▲|PM193.93+2.87 (+1.50%) ▲|QCOM179.12-2.85 (-1.57%) ▼|RTX194.66-3.03 (-1.53%) ▼|SBUX98.86+0.12 (+0.12%) ▲|SCHW106.98-0.27 (-0.25%) ▼|SO86.85-0.33 (-0.37%) ▼|SPG204.76-0.08 (-0.04%) ▼|T26.44+0.38 (+1.46%) ▲|TMO612.15+2.33 (+0.38%) ▲|TMUS183.99+1.66 (+0.91%) ▲|TSLA362.69-2.75 (-0.75%) ▼|TXN264.64-4.06 (-1.51%) ▼|UBER72.76+1.09 (+1.52%) ▲|UNH384.33+7.56 (+2.01%) ▲|UNP284.54+0.14 (+0.05%) ▲|UPS101.69+1.41 (+1.41%) ▲|USB62.38-0.46 (-0.73%) ▼|V376.34+5.89 (+1.59%) ▲|VZ51.30+0.69 (+1.35%) ▲|WFC87.69-2.60 (-2.88%) ▼|WMT109.49+2.34 (+2.18%) ▲|XOM165.46-0.54 (-0.32%) ▼|AAPL334.51+2.24 (+0.67%) ▲|ABBV261.43+4.31 (+1.68%) ▲|ABT102.95+1.00 (+0.98%) ▲|ACN194.28+10.38 (+5.64%) ▲|ADBE264.86+12.63 (+5.01%) ▲|AMAT426.96-29.53 (-6.47%) ▼|AMD494.09-22.05 (-4.27%) ▼|AMGN380.37+3.02 (+0.80%) ▲|AMT177.20-0.65 (-0.37%) ▼|AMZN255.59-1.19 (-0.46%) ▼|AVGO346.64-15.36 (-4.24%) ▼|AXP326.91+2.22 (+0.68%) ▲|BA210.37-0.09 (-0.04%) ▼|BAC60.11-2.59 (-4.12%) ▼|BKNG175.20+1.28 (+0.74%) ▲|BLK1,066.89-12.76 (-1.18%) ▼|BMY64.12+0.48 (+0.75%) ▲|BNY158.30-4.36 (-2.68%) ▼|BRK-B513.81+3.44 (+0.67%) ▲|C133.83-4.99 (-3.59%) ▼|CAT786.08-32.50 (-3.97%) ▼|CL88.34+1.54 (+1.77%) ▲|CMCSA24.98-0.22 (-0.87%) ▼|COF207.37-0.94 (-0.45%) ▼|COP137.69+0.34 (+0.25%) ▲|COST917.05+12.28 (+1.36%) ▲|CRM258.90+11.18 (+4.51%) ▲|CSCO111.49-0.65 (-0.58%) ▼|CVS95.67+1.01 (+1.07%) ▲|CVX213.68-0.39 (-0.18%) ▼|DE681.39+5.65 (+0.84%) ▲|DHR203.41+3.27 (+1.63%) ▲|DIS109.18+2.63 (+2.47%) ▲|DUK118.88-0.54 (-0.45%) ▼|EMR148.37-3.82 (-2.51%) ▼|FDX311.61+0.84 (+0.27%) ▲|GD356.78+0.88 (+0.25%) ▲|GE317.29-6.38 (-1.97%) ▼|GEV873.25-84.02 (-8.78%) ▼|GILD145.74+2.02 (+1.41%) ▲|GM86.41+0.79 (+0.92%) ▲|GOOG345.45+10.00 (+2.98%) ▲|GOOGL348.92+10.42 (+3.08%) ▲|GS990.42-38.76 (-3.77%) ▼|HD310.54+1.80 (+0.58%) ▲|HON199.12-3.25 (-1.60%) ▼|IBM250.89+7.60 (+3.12%) ▲|INTC98.29-4.66 (-4.52%) ▼|INTU338.38+16.81 (+5.23%) ▲|ISRG376.21+7.06 (+1.91%) ▲|JNJ267.88+2.30 (+0.87%) ▲|JPM349.21-7.02 (-1.97%) ▼|KO89.14+0.85 (+0.96%) ▲|LIN464.53-1.70 (-0.36%) ▼|LLY1,145.82+30.12 (+2.70%) ▲|LMT527.84+3.65 (+0.70%) ▲|LOW198.37+1.55 (+0.79%) ▲|LRCX275.82-22.41 (-7.51%) ▼|MA575.04+5.85 (+1.03%) ▲|MCD257.19+4.66 (+1.85%) ▲|MDLZ62.38-0.06 (-0.10%) ▼|MDT93.31+2.35 (+2.58%) ▲|META664.45+16.42 (+2.53%) ▲|MMM162.01-2.96 (-1.79%) ▼|MO70.55+1.57 (+2.27%) ▲|MRK145.46+1.53 (+1.06%) ▲|MS207.18-7.21 (-3.36%) ▼|MSFT509.20+13.57 (+2.74%) ▲|MU926.10-49.17 (-5.04%) ▼|NEE82.21-0.10 (-0.12%) ▼|NFLX80.75+3.35 (+4.32%) ▲|NKE37.15+0.35 (+0.94%) ▲|NOW143.13+10.60 (+7.99%) ▲|NVDA212.42-5.88 (-2.69%) ▼|ORCL143.85-6.44 (-4.28%) ▼|PEP136.61+0.29 (+0.21%) ▲|PFE27.78+0.06 (+0.20%) ▲|PG146.24+0.97 (+0.67%) ▲|PLTR173.30+6.07 (+3.63%) ▲|PM193.93+2.87 (+1.50%) ▲|QCOM179.12-2.85 (-1.57%) ▼|RTX194.66-3.03 (-1.53%) ▼|SBUX98.86+0.12 (+0.12%) ▲|SCHW106.98-0.27 (-0.25%) ▼|SO86.85-0.33 (-0.37%) ▼|SPG204.76-0.08 (-0.04%) ▼|T26.44+0.38 (+1.46%) ▲|TMO612.15+2.33 (+0.38%) ▲|TMUS183.99+1.66 (+0.91%) ▲|TSLA362.69-2.75 (-0.75%) ▼|TXN264.64-4.06 (-1.51%) ▼|UBER72.76+1.09 (+1.52%) ▲|UNH384.33+7.56 (+2.01%) ▲|UNP284.54+0.14 (+0.05%) ▲|UPS101.69+1.41 (+1.41%) ▲|USB62.38-0.46 (-0.73%) ▼|V376.34+5.89 (+1.59%) ▲|VZ51.30+0.69 (+1.35%) ▲|WFC87.69-2.60 (-2.88%) ▼|WMT109.49+2.34 (+2.18%) ▲|XOM165.46-0.54 (-0.32%) ▼|
22.2 C
New York
Monday, September 14, 2026

Tag: data

Bavarian Nordic Receives Acceptance from Health Canada for Review of the New Drug Submission for its Chikungunya Vaccine

COPENHAGEN, Denmark, July 22, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that Health Canada has accepted for review the Company’s application for licensure of the single-dose, virus-like particle (VLP) chikungunya vaccine candidate, CHIKV VLP, for immunization to prevent disease caused by chikungunya virus infection in individuals 12 years of age and older. The application screening acceptance by the Directorate confirms that the New Drug Submission is complete and begins a standard review procedure, potentially supporting approval of the vaccine in the first half of 2026.

Accounting Automation Tools (2025): QuickBooks Awarded Best Accounting Automation Solution in Report by Better Business Advice

NEW YORK, July 22, 2025 /PRNewswire/ -- Better Business Advice has named QuickBooks the Best Accounting Automation Solution of 2025, citing its significant advancements in...

JOHNSON CONTROLS EXPANDS YORK® YVAM AIR-COOLED MAGNETIC BEARING CHILLER TO AUSTRALIA TO MEET GROWING DATA CENTRE DEMAND

SYDNEY, July 22, 2025 /PRNewswire/ -- Johnson Controls (NYSE: JCI), the global leader for smart, safe, healthy and sustainable buildings, has expanded availability of its industry-leading...

Regal Rexnord Corporation Declares Quarterly Dividend of $.35 per share.

MILWAUKEE, Wis., July 21, 2025 /PRNewswire/ -- Louis Pinkham, Chief Executive Officer of Regal Rexnord Corporation (NYSE: RRX), announced that the Board of Directors,...

DualityBio’s Next-Generation HER3 ADC DB-1310 Granted FDA Fast Track Designation

SHANGHAI, July 21, 2025 /PRNewswire/ -- DualityBio (HKEX Stock Code: 9606.HK) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track...

Precision Era to Redefine Treatment, Drive $450B Economic Investment and Change Lives Across Asia Pacific

SINGAPORE, July 22, 2025 /PRNewswire/ -- The Precision Era of medicine is arriving in Asia Pacific, driven by the arrival of a critical mass...

OMRON Healthcare Singapore partners with bolttech and QBE to launch innovative embedded health solution

The comprehensive subscription programme offers OMRON customers in Singapore access to personalised health protection and insights SINGAPORE, July 22, 2025 /PRNewswire/ -- Global insurtech bolttech...

EISAI TO PRESENT FOUR-YEAR EFFICACY AND SAFETY DATA ON CONTINUOUS TREATMENT WITH LECANEMAB AT THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2025

Latest findings from Eisai's robust Alzheimer's disease (AD) pipeline include results from lecanemab long-term data, an immunoassay for measuring amyloid-β protofibrils in cerebrospinal fluid,...

Biogen to Highlight Scientific Progress Across Alzheimer’s Disease at the Alzheimer’s Association International Conference 2025

CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced upcoming scientific presentations at the 2025 Alzheimer’s Association International Conference (AAIC), taking place July 27-31 in Toronto, Canada. Data on LEQEMBI® (lecanemab) will include 48-month results from the Clarity AD open-label extension, real-world evidence, and new insights into a subcutaneous formulation for maintenance dosing. Presentations on tau will explore tau-targeted therapies and biomarkers, including baseline characteristics of participants from CELIA, a Phase 2 trial evaluating the efficacy, safety, and tolerability of BIIB080, an investigational antisense oligonucleotide (ASO) therapy that targets tau.

XRP surges 100% to $3.66, PBKMiner launches free XRP mining contracts to attract a large number of XRP holders

Washington, D.C, July 21, 2025 (GLOBE NEWSWIRE) -- Driven by US cryptocurrency legislation, Ripple XRP surged to $3.65, a record high. PBKMiner provides an AI-driven approach: XRP dedicated cloud mining contracts, allowing users to use Ripple (XRP) to immediately start Bitcoin cloud mining to achieve daily XRP and BTC daily income.
Ripple's native token, XRP, hit a new all-time high of $3.65, reaching a major milestone. The surge came after the U.S. House of Representatives passed two important cryptocurrency-focused legislative bills, the GENIUS Act and the CLARITY Act. The GENIUS Act represents the framework to establish the first federally regulated stablecoin system, and Ripple's RLUSD is expected to serve as its underlying asset.

XRP breaks through resistance and price surges 90%, PBK Miner launches revolutionary XRP cloud mining, igniting the XRP market

Los Angeles, California, July 21, 2025 (GLOBE NEWSWIRE) -- XRP has had a great week, hitting an eye-popping $3.66 on Friday, a massive 90% increase from April levels. Now just a stone’s throw away from XRP’s legendary peak of $3.84 during the 2018 bull run, as enthusiasm in the cryptocurrency market soars, PBKMiner has officially launched a groundbreaking innovation: Ripple’s XRP cloud mining contract – no hardware required, daily rewards, and fully remote access for users around the world.
The upward trend continues as global financial institutions increasingly adopt Ripple's liquidity framework. As tokenized assets and stablecoins gradually become mainstream, XRP is more than just a cryptocurrency, it is gradually becoming the backbone of Ripple's plan to unlock more than $100 trillion in global liquidity. As a neutral digital bridge asset, XRP enables fast settlement between different currencies, assets and networks.

PBK Miner launches the first XRP cloud mining platform, leading the Ripple cloud mining revolution, using XRP to earn daily passive income

Riding on the bullish momentum of XRP’s recovery, PBKMiner announced the official launch of its AI-powered XRP cloud mining contracts — daily payouts, zero hardware, and full automation are now available to users worldwide.
Riding on the bullish momentum of XRP’s recovery, PBKMiner announced the official launch of its AI-powered XRP cloud mining contracts — daily payouts, zero hardware, and full automation are now available to users worldwide.

CHAMPION IRON ENTERS INTO A DEFINITIVE AGREEMENT WITH NIPPON STEEL AND SOJITZ TO FORM A PARTNERSHIP FOR THE KAMI PROJECT

MONTRÉAL, July 21, 2025 /CNW/ - SYDNEY, July 22, 2025 - Champion Iron Limited (TSX: CIA) (ASX: CIA) (OTCQX: CIAFF) ("Champion" or the "Company") announces...

IEQ Capital Welcomes Lauren Garner as Managing Director

SAN FRANCISCO, July 21, 2025 /PRNewswire/ -- IEQ Capital ("IEQ"), an independent advisory firm managing approximately $41.7 billion in regulatory assets under management (RAUM)* and...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsData